Harding Loevner LP Cuts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Harding Loevner LP trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 7.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 819,429 shares of the healthcare conglomerate’s stock after selling 68,538 shares during the quarter. UnitedHealth Group makes up 2.2% of Harding Loevner LP’s holdings, making the stock its 15th biggest position. Harding Loevner LP owned approximately 0.09% of UnitedHealth Group worth $399,203,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Vanguard Group Inc. boosted its stake in shares of UnitedHealth Group by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 80,630,913 shares of the healthcare conglomerate’s stock valued at $41,119,347,000 after purchasing an additional 1,147,051 shares in the last quarter. State Street Corp boosted its position in UnitedHealth Group by 1.9% during the 4th quarter. State Street Corp now owns 45,559,868 shares of the healthcare conglomerate’s stock valued at $22,877,432,000 after buying an additional 869,827 shares during the period. Capital International Investors boosted its position in UnitedHealth Group by 4.3% during the 4th quarter. Capital International Investors now owns 19,342,468 shares of the healthcare conglomerate’s stock valued at $9,713,058,000 after buying an additional 790,219 shares during the period. Geode Capital Management LLC raised its holdings in UnitedHealth Group by 1.2% in the 4th quarter. Geode Capital Management LLC now owns 15,618,069 shares of the healthcare conglomerate’s stock worth $7,821,210,000 after purchasing an additional 189,864 shares in the last quarter. Finally, Alliancebernstein L.P. raised its holdings in UnitedHealth Group by 2.4% in the 4th quarter. Alliancebernstein L.P. now owns 11,015,163 shares of the healthcare conglomerate’s stock worth $5,531,154,000 after purchasing an additional 257,910 shares in the last quarter. Institutional investors own 87.25% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $524.34 on Friday. The business has a 50-day moving average of $528.73 and a 200 day moving average of $510.20. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77. The stock has a market capitalization of $490.46 billion, a price-to-earnings ratio of 27.38, a price-to-earnings-growth ratio of 1.64 and a beta of 0.76. UnitedHealth Group Incorporated has a 12 month low of $383.12 and a 12 month high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, topping the consensus estimate of $5.24 by $0.33. The business had revenue of $80.33 billion for the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The business’s quarterly revenue was up 12.6% on a year-over-year basis. During the same quarter last year, the company earned $4.70 EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th will be issued a $1.65 dividend. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.26%. The ex-dividend date is Friday, September 9th. UnitedHealth Group’s payout ratio is currently 34.46%.

Insider Activity

In other news, CEO Dirk C. Mcmahon sold 14,715 shares of the business’s stock in a transaction that occurred on Thursday, August 18th. The stock was sold at an average price of $543.32, for a total value of $7,994,953.80. Following the transaction, the chief executive officer now owns 50,108 shares of the company’s stock, valued at $27,224,678.56. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, CAO Thomas E. Roos sold 465 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the sale, the chief accounting officer now directly owns 34,786 shares in the company, valued at $18,866,882.82. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Dirk C. Mcmahon sold 14,715 shares of the business’s stock in a transaction on Thursday, August 18th. The stock was sold at an average price of $543.32, for a total value of $7,994,953.80. Following the sale, the chief executive officer now owns 50,108 shares in the company, valued at $27,224,678.56. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 140,324 shares of company stock valued at $75,086,185. Company insiders own 0.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on UNH. Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $613.00 to $612.00 and set an “overweight” rating on the stock in a report on Wednesday, May 25th. Oppenheimer raised their price objective on shares of UnitedHealth Group from $600.00 to $610.00 and gave the stock an “outperform” rating in a report on Monday, July 18th. Mizuho raised their price objective on shares of UnitedHealth Group from $550.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, August 10th. Argus raised their price objective on shares of UnitedHealth Group from $580.00 to $650.00 and gave the stock a “buy” rating in a report on Monday, July 25th. Finally, BMO Capital Markets raised their target price on shares of UnitedHealth Group from $600.00 to $610.00 in a research note on Wednesday, July 20th. Three equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $585.65.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Recommended Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.